Effect of cholinomimetic drugs in combination with amfonelic acid or spiperone on the concentration of 3,4-dihydroxyphenylacetic acid in rat brain.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D002090:Butyrophenones / Q000494:pharmacology*; D004347:Drug Interactions; D008297:Male; D009268:Nalidixic Acid / Q000031:analogs & derivatives; D009287:Naphthyridines / Q000494:pharmacology*; D010095:Oxotremorine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010648:Phenylacetates / Q000378:metabolism*; D010862:Pilocarpine / Q000494:pharmacology; D051381:Rats; D013134:Spiperone / Q000494:pharmacology*
D002090:Butyrophenones; D009287:Naphthyridines; D010277:Parasympathomimetics; D010648:Phenylacetates; D010862:Pilocarpine; D015102:3,4-Dihydroxyphenylacetic Acid; D009268:Nalidixic Acid; D013134:Spiperone; D010095:Oxotremorine; C006486:amfonelic acid